Mineralys Therapeutics, Inc. MLYS Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
- Mineralys Therapeutics, Inc. (MLYS) reported increase (decrease) in prepaid expense and other assets of $1.95M in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
- Mineralys Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 55.7% year-over-year, from $4.4M to $1.95M.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
- Over 2 years (2022 to 2025), Mineralys Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a 5.0% compound annual growth rate (CAGR), from $2.24M to -$2.47M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.